Autoinjectors Market Size, Share, and Growth Insights
DataM Intelligence published a business research report on the Autoinjectors Market by Type, By Technology, By Therapy, By End User, and By Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts for 2022–2029. Autoinjectors market report with 110+ market data Tables, Pie Chat, Graphs, and Figures spread concluded Pages and easy to comprehend complete analysis. The data is collected based on modern floats and requests acknowledged with the administrations and items.
The Autoinjectors market study comprises historic data, current market trends, environment, technological innovation, upcoming technologies, and the technical progress in the correlated industry. The autoinjectors research report offers a complete, proficient report delivering market research information that is related to new market entrants or set up players. Key strategies of the companies operating in the market and their effect analysis have been comprised in the full report.
According to the Study conducted by DataM Intelligence, the global Autoinjectors market size is projected to reach at a decent value in billion USD by the end of 2029, with growth at a CAGR of 19.2% During the forecast period 2021-2029.
Download Sample Brochure to understand our research methodology, regional analysis, and competitive insights @ https://www.datamintelligence.com/download-sample/autoinjectors-market
What are Autoinjectors?
Autoinjectors are self-injectable devices that can deliver drugs through subcutaneous or intramuscular routes. They hold prefilled syringes or cartridges which are driven by a spring system. The major advantages of this device are comfortable self-administration, enhanced patient compliance, decreased anxiety, and dosage precision.
Autoinjectors Market Growth Drivers Analysis:
The global autoinjectors market growth is driven by technological advancements, an increasingly aging population, a rising prevalence of chronic diseases such as cancer and diabetes, rising patient healthcare expenditure and growing research and development activities. An increasing number of chronic diseases such as cancer and diabetes drives the market growth
The growing number of chronic diseases, such as cancer and diabetes, boosts the autoinjectors market worldwide. According to the World Health Organization (WHO), a globally agreed target is to halt the advancement in diabetes and obesity by 2025.
In September 2021, Owen Mumford Pharmaceutical Services introduced its new Aidaptus autoinjector platform. The new device is a 2-step, spring-powered, single-use autoinjector designed to accommodate 1 mL and 2.25 mL prefilled glass syringes in the same base device. Also, in May 2022, Halozyme Therapeutics, Inc. acquired Antares Pharma, Inc. The combination of Halozyme and Antares will create a leading drug delivery and specialty product company.
Know how the Global Autoinjectors Market was impacted by COVID-19:
The COVID-19 epidemic has quickened the trend of self-injection, allowing patients to become more active and in control of their treatment. The direction has promoted newer technologies in the autoinjectors market for enhanced injection speed regulation, injection site pain, and treat anxiety.
In addition, the new products launched by key players are driving the market during the COVID-19 pandemic. For instance, in April 2020, Teva Pharmaceuticals USA, Inc. announced that the autoinjector device for AJOVY (fremanezumab-vfrm) injection is available in the United States. AJOVY is implied for the preventive treatment of migraine in adults and is the only anti-CGRP (calcitonin gene-related peptide) preventive migraine treatment with quarterly (675 mg) and monthly (225 mg) subcutaneous dosing options. Also, in September 2021, Novartis reported data from an international Phase IIIb study, which delivered treatment with Cosentyx (secukinumab) 300 mg in a 2 mL autoinjector (UnoReady pen) resulted in high effectiveness and proper administration in adults with mild to severe plaque psoriasis1. These data were presented at the European Academy of Dermatology and Venereology’s 30th Anniversary Congress.
Browse Full Report Description to know about market overview @ https://www.datamintelligence.com/research-report/autoinjectors-market
Autoinjectors Market Segmentation Analysis:
By Type: Disposable Autoinjectors, and Reusable Autoinjectors
The disposable autoinjectors segment accounts for the largest market share. As per the article published in Saudi Pharmaceutical Journal in October 2021, More than 20 pharmaceutical companies have developed nearly 80 autoinjectors. Nearly 50 drugs are developed as combination products for administration using autoinjectors. Among these, 62% of the autoinjectors are disposable.
By Technology: Manual Autoinjectors, and Automated Autoinjectors
The automated autoinjectors segment led the global market in 2020. Increasing preference for these automated autoinjectors among the patient population, particularly during emergencies, and raising awareness through campaigns are significantly pushing the growth of this segment.
By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, and Others
By End-User: Home Care Setting, and Hospitals
Geographical Classification of the Global Market:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
North America Autoinjectors Market Insights
North America dominates the market for autoinjectors and is expected to show a similar trend over the forecast period. The market is driven by factors such as FDA approval for products, regional key players, advanced healthcare facilities, and rising chronic diseases.
The product launches by key players are driving the autoinjectors market in the North American region. For instance, in June 2020, Mylan N.V. and Biocon Ltd. announced the USFDA approval of the New Drug Application for Semglee (insulin glargine injection) in the vial and pre-filled pen forms to control high blood sugar in adults with type 2 diabetes and adult and pediatric patients with type-1 diabetes.
Europe Autoinjectors Market Insights
Europe region had engaged the second-largest share in the global autoinjectors market in 2021. The European market is projected to produce at a high CAGR over the forecast period 2021-2029. In the European region, the German Autoinjectors market is projected to control the European autoinjectors market accounting for a considerable share throughout the forecast period 2021-2029.
Make an Inquire before purchasing the full report @ https://www.datamintelligence.com/enquiry/autoinjectors-market
Asia Pacific Autoinjectors Market Insights
The Asia Pacific is projected to have a substantial growth rate throughout the forecast period owing to the rising occurrence of a number of diabetic patient and growing population. In Asia Pacific region, economies are allowing and emerging innovative products enhancing the growth of the market. Likewise, India, China, and Japan are predictable to contribute intentionally to the Autoinjectors market growth.
Latin America Autoinjectors Market Insights
The Latin American Autoinjectors Market is predicted to produce a decent CAGR during the forecast period. Brazil is one of the leading countries, followed by Mexico, Argentina, and Columbia.
Middle East and African Autoinjectors Market Insights
The Middle East and Africa Autoinjectors Market is predictable to have slow growth during the forecast period 2021-2029. The development of the market is accredited owing to the lacking healthcare infrastructure, mainly in the African region.
Competitive Landscape and Key Companies Profiled in the Global Autoinjectors Market
The autoinjectors market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Kaléo, AbbVie, Amgen, Biogen Idec, AstraZeneca, Mylan, Pfizer, Teva Pharmaceuticals, Biogen, Eli Lilly, Merck & Co, Sandoz, Johnson &Johnson, YpsoMed, and Becton Dickinson and Company, among others. The major players are adopting several growth strategies such as Type launches, acquisitions, and collaborations, contributing to the global autoinjectors growth.
- In February 2021, Becton Dickinson (BD) developed Intevia 2.25 mL based on thinner wall cannula technology. The Intevia 2.25 mL is a patient-centric device that works seamlessly with BD Neopak XtraFlow prefillable syringes and has an 8-millimeter needle with a thinner wall.
- In March 2020, SHL medical acquired Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
Table of Content – Autoinjectors Market
- Methodology and Scope
- Research Methodology
- Research Objective and Scope of the Report
- Market Definition and Overview
- Executive Summary
- Global Dynamics
- Industry Analysis
- By Type
- By Technology
- By Therapy
- By End-User
- By Region
- Competitive Landscape
- Company Profiles
Wearable Injectors Market is Segmented By Type (Off-Body Injectors, Infusion Sets, Others ), By Therapy( Autoimmune Disease, Diabetes, Cardiovascular Disease, Other), By End-User (Hospitals and Clinics, Homecare, Others), By End-User (Automotive, Aerospace, Safety, Medical, Energy, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
Facial Injections Market is segmented By Injection Material Type (Collagen, Hyaluronic Acid, Calcium Hydroxyl Apatite, Botulinum Toxin), By Application Type (Facial Line Correction, Lip Augmentation, Face Lift, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Injection Pen Market is Segmented By Type (Disposable injection pens, Reusable injection pens), By Application (Diabetes, Growth Hormone, Osteoporosis, Fertility, Other), By End-User (Home-care Settings, Hospitals & Diagnostic Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Microinjection Molding Machine Market Segmented By Clamping Force, By Type, By Application, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Additional Benefits Post Purchase:
1) Unlimited Analyst support for a period of 1 year.
2) Any query with regard to the scope offered will be addressed within 24- 48 hours.
3) An excel sheet with market numbers will be provided separately
DataM Intelligence 4Market Research is a market intelligence platform which gives access to syndicated, customized reports and consulting to its clients at one place. As a firm with rich experience in research and consulting across multiple domains we are one stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed and food & beverages among others.
Our platform has Insights on markets that uncover latest market research data that’s distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy centric framework and value-added services will let individuals and corporates with ease of access and custom personalization to research and markets.